Literature DB >> 16915405

Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study.

Wenhui Jiang1, Aiqun Ma, Tingzhong Wang, Ke Han, Yu Liu, Yanmin Zhang, Anping Dong, Yuan Du, Xin Huang, Jun Wang, Xinjun Lei, Xiaopu Zheng.   

Abstract

Mesenchymal stem cells (MSCs) are potential sources of cells for tissue repair. However, little information is available about the time course of homing and differentiation of systemically delivered MSCs after acute myocardial ischemia (MI). In the present study, MSCs were isolated from male rat bone marrow and expanded in vitro. Female rats were divided randomly into three groups. Three hours after coronary ligation, the transplanted group received an infusion of MSCs through the tail vein; at the same time, a coronary-ligated control group was injected with culture medium, and a normal (unligated) group received MSCs. Homing of MSCs to the heart was assessed by expression of the Y chromosome sry gene using fluorescence in situ hybridization (FISH) at 3 days, 1, 4, and 8 weeks after transplantation. Immunofluorescent staining was used to examine markers for cardiomyocytes, endothelial cells, and smooth muscle cells. Hemodynamics in the hearts was also measured to assess cardiac function. At each time point, sry-positive cells were present in the cardiac tissue in transplanted group but not in the hearts of normal and control group animals. The number of sry-positive cells was significantly higher at 1 week compared to 3 days after transplantation. No significant difference was found in the number of sry-positive cells among those of 1, 4, and 8 weeks after transplantation. At 3 days and 1 week after transplantation, the sry-positive cells in the transplanted group lacked troponin, desmin, smooth muscle alpha-actin, and CD31. At the later time points, cardiomyocytes, smooth muscle cells, and endothelial cells bearing sry were identified in the transplanted group. The cardiac function in transplanted group showed higher improvement at 4 and 8 weeks compared to 1 week after transplantation. Our data suggest that intravenously delivered MSCs are capable of homing toward the ischemic myocardium, and the fastigium of homing appeared around 1 week after MI. The differentiation of MSCs to cardiomyocytes, smooth muscle cells, and endothelial cells shows to be time dependent and arises at 1 to 4 weeks after transplantation.

Entities:  

Mesh:

Year:  2006        PMID: 16915405     DOI: 10.1007/s00424-006-0117-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  26 in total

1.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

2.  Neuroscience. Cellular interactions in the stem cell niche.

Authors:  Andrew E Wurmser; Theo D Palmer; Fred H Gage
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

Review 3.  Bone marrow stem cell transplantation for cardiac repair.

Authors:  Husnain Kh Haider; Muhammad Ashraf
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06       Impact factor: 4.733

4.  Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects.

Authors:  Wangde Dai; Sharon L Hale; Bradley J Martin; Jin-Qiang Kuang; Joan S Dow; Loren E Wold; Robert A Kloner
Journal:  Circulation       Date:  2005-07-05       Impact factor: 29.690

5.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

Authors:  J Dawn Abbott; Yan Huang; Dingang Liu; Reed Hickey; Diane S Krause; Frank J Giordano
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

7.  In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions.

Authors:  Fernando Anjos-Afonso; Elena K Siapati; Dominique Bonnet
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

Review 8.  Mesenchymal stem cells and their potential as cardiac therapeutics.

Authors:  Mark F Pittenger; Bradley J Martin
Journal:  Circ Res       Date:  2004-07-09       Impact factor: 17.367

9.  Modulation of hematopoietic stem cell homing and engraftment by CD26.

Authors:  Kent W Christopherson; Giao Hangoc; Charlie R Mantel; Hal E Broxmeyer
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

10.  Mesenchymal stem cells avoid allogeneic rejection.

Authors:  Jennifer M Ryan; Frank P Barry; J Mary Murphy; Bernard P Mahon
Journal:  J Inflamm (Lond)       Date:  2005-07-26       Impact factor: 4.981

View more
  28 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 2.  Stem cells: novel players in the treatment of erectile dysfunction.

Authors:  Haiyang Zhang; Maarten Albersen; Xunbo Jin; Guiting Lin
Journal:  Asian J Androl       Date:  2011-10-17       Impact factor: 3.285

3.  Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair.

Authors:  David L Simpson; Nolan L Boyd; Sunjay Kaushal; Steve L Stice; Samuel C Dudley
Journal:  Biotechnol Bioeng       Date:  2011-09-02       Impact factor: 4.530

4.  Direct mechanical measurement of geodesic structures in rat mesenchymal stem cells.

Authors:  P Maguire; J I Kilpatrick; G Kelly; P J Prendergast; V A Campbell; B C O'Connell; S P Jarvis
Journal:  HFSP J       Date:  2007-09-19

5.  In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement.

Authors:  Young Jin Kim; Yong-Min Huh; Kyu Ok Choe; Byoung Wook Choi; Eun Jeong Choi; Yangsoo Jang; Jae Myun Lee; Jin-Suck Suh
Journal:  Int J Cardiovasc Imaging       Date:  2009-01-09       Impact factor: 2.357

6.  Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model.

Authors:  Fanglong Song; Jilei Tang; Rui Geng; Hansheng Hu; Chunhui Zhu; Weiding Cui; Weimin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

7.  Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits.

Authors:  Bai-Chin Lee; Hsiu-Ching Hsu; Wen-Yih I Tseng; Ching-Yi Chen; Hung-Ju Lin; Yi-Lwun Ho; Ming-Jai Su; Ming-Fong Chen
Journal:  Eur J Heart Fail       Date:  2009-01-12       Impact factor: 15.534

8.  Molecular mechanisms involved in mesenchymal stem cell migration to the site of acute myocardial infarction.

Authors:  Katarina Kollar; Matthew M Cook; Kerry Atkinson; Gary Brooke
Journal:  Int J Cell Biol       Date:  2009-07-12

9.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.

Authors:  Simi M Chacko; Mahmood Khan; M Lakshmi Kuppusamy; Ramasamy P Pandian; Saradhadevi Varadharaj; Karuppaiyah Selvendiran; Anna Bratasz; Brian K Rivera; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 10.  Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help?

Authors:  David Simpson; Samuel C Dudley
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.